BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Medix ProClot

medixproclot.com/United States
1 profile visit

About

我們 是一家總部位於美國喬治亞州、具備矽谷敏捷思維的醫療科技新創。公司由來自美國的連續創業家領軍,結合美商的資本速度與臺灣頂尖的醫療製造實力(FDA/TFDA 認證 CMO),專注於研發「人寵雙用 (Human & Veterinary Dual-Use)」更方便購買且2分鐘抑制主動脈出血

我們不走傳統生技公司動輒數年、燒光資金的舊路,而是以精實創業(Lean Startup)的敏捷模式,專注於單一突破性 MVP的全球規模化。成立第一年即展現極強的亞太拉力,正全面顛覆被國際巨頭壟斷的傳統止血市場

為什麼國際頂尖經銷商選擇放棄龍頭品牌,轉向與我們合作?

美國創業家視野 × 亞太文化洞察:CEO 帶入美商高效率營運體系,同時精準切入亞太「處方藥門檻」與龐大的個人/寵物急救剛需

實測效能超越巨頭:產品止血速度與方便性實測超越傳統 Trauma Gel,改寫日常與戶外急救標準

顛覆性的經銷商合作模式:傳統巨頭塞貨、層級過多且缺乏在地客服;我們提供高毛利、去中間化且極具彈性的合作架構,已吸引多國龍頭代理商主動洽談

強勁的有機市場拉力:完全不靠折扣與廣告,首年即簽署 APAC 4 國 MOU、展覽現場累積 160+ 組預購等待名單,並接獲國軍單位主動聯繫

Social media

Areas of activity

Technology

Bio-Tech

Additional information

Other Place of Business

Western EuropeNorth Africa North AmericaLatin America & CaribbeanSouth-East AsiaEast AsiaMiddle East

Year of Establishment

2020

Company Funding Stage

Seed & Pre-Series

Service Introduction

Medix is a pioneering medical technology company specializing in advanced trauma hemostasis solutions, best known for its proprietary ProClot hemostatic gel and powder across clinical medicine, emergency response, and veterinary care.

For rapid hemorrhage control in both surgical settings and veterinary care

Actively scales international footprint across North America, Southeast Asia, the Middle East, and Africa while securing key regulatory approvals, including FDA clearance.

At which key stages of the project lifecycle are your services appropriately applied?

Feasibility AssessmentFinancing and InsuranceMarket Assessment and Project SelectionRisk Planning

Terms and Conditions & Disclaimer

I agree

Representatives

Regional Director

Medix ProClot

Marketplace (1)

  • Project

    Medix ProClot

    For human/pet use, Gel & Powder & Gauze Led by a US serial founder, outperforms legacy trauma products. Co-developed with a Med Univ VP. 4 APAC MOUs in Yr 1 with 0 ad spend & + Higher partner margins. Book a 1-on-1!

    • Yes
    • Yes
    • Equity
    • Bio-Tech
    • Technology
    • E-commerce
    • Private Project
    • Private Banking
    • Health Technology
    • Health Facilities
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Commercial Banking
    • Investment Banking
    • Open for negotiation
    • Open for Negotiation
    • Professional Services
    • Mergers & Acquisition
    • 2,500,001 to 5,000,000 USD
    • 7,500,001 to 10,000,000 USD
    • Private Equity & Venture Capital
    • Investment / Financing Discussion
    Author

    Regional Director at Medix ProClot

    Taiwan